Skip to main content
Article thumbnail
Location of Repository

Moderate Champagne consumption promotes an acute improvement in acute endothelial-independent vascular function in healthy human volunteers

By D. Vauzour, E.J. Houseman, T.W. George, G. Corona, R. Garnotel, K.G. Jackson, C. Sellier, P. Gillery, O.B. Kennedy, J.A. Lovegrove and J.P.E. Spencer

Abstract

Epidemiological studies have suggested an inverse correlation between red wine consumption and the incidence of CVD. However, Champagne wine has not been fully investigated for its cardioprotective potential. In order to assess whether acute and moderate Champagne wine consumption is capable of modulating vascular function, we performed a randomised, placebo-controlled, cross-over intervention trial. We show that consumption of Champagne wine, but not a control matched for alcohol, carbohydrate and fruit-derived acid content, induced an acute change in endothelium-independent vasodilatation at 4 and 8 h post-consumption. Although both Champagne wine and the control also induced an increase in endothelium-dependent vascular reactivity at 4 h, there was no significant difference between the vascular effects induced by Champagne or the control at any time point. These effects were accompanied by an acute decrease in the concentration of matrix metalloproteinase (MMP-9), a significant decrease in plasma levels of oxidising species and an increase in urinary excretion of a number of phenolic metabolites. In particular, the mean total excretion of hippuric acid, protocatechuic acid and isoferulic acid were all significantly greater following the Champagne wine intervention compared with the control intervention. Our data suggest that a daily moderate consumption of Champagne wine may improve vascular performance via the delivery of phenolic constituents capable of improving NO bioavailability and reducing matrix metalloproteinase activity

Publisher: Cambridge University Press
Year: 2010
OAI identifier: oai:centaur.reading.ac.uk:12901

Suggested articles

Citations

  1. (2007). (2)-Epicatechin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase.
  2. (2002). A new automated method for the determination of the total antioxidant capacity (TAC) of human plasma, based on the crocin bleaching assay.
  3. (1992). Alcohol and mortality.
  4. (2005). Antiatherogenic potential of red wine: clinician update.
  5. (2003). Antihypertensive effect of a low molecular weight fraction (1 kDa) of champagne wine in spontaneously hypertensive rats.
  6. (1996). Antioxidants in human health and disease.
  7. (1999). Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.
  8. (2003). Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans.
  9. (2007). Coffee drinking induces incorporation of phenolic acids into LDL and increases the resistance of LDL to ex vivo oxidation in humans.
  10. (1998). Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. doi
  11. (2003). Defenses against peroxynitrite: selenocompounds and flavonoids.
  12. (2006). Detection of sequencespecific tyrosine nitration of manganese SOD and SERCA in cardiovascular disease and aging.
  13. (2000). Dietary intake and bioavailability of polyphenols.
  14. (2005). Dietary polyphenols and regulation of gelatinase expression and activity. doi
  15. (1998). Differential expression of tissue inhibitors of metalloproteinases in the failing human heart.
  16. (2004). Direct effect of ethanol on human vascular function.
  17. (2000). Does a glass of red wine improve endothelial function?
  18. (2003). Dual method for the determination of peroxidase activity and total peroxidesiodide leads to a significant increase of peroxidase activity in human sera. doi
  19. (2005). Early and late effects of alcohol ingestion on blood pressure and endothelial function.
  20. (2001). Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery.
  21. (2003). Effect of alcohol on endothelial function in healthy subjects.
  22. (2008). Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation.
  23. (2001). Effect of red wine and ethanol on production of nitric oxide in healthy subjects.
  24. (1998). Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries.
  25. (2003). Effects of virgin olive oil phenolic compounds on LDL oxidation and vasorelaxation activity.
  26. (2002). Elimination of electrically induced iontophoretic artefacts: implications for non-invasive assessment of peripheral microvascular function. doi
  27. (2001). Endothelin-1 synthesis reduced by red wine.
  28. (1993). Endothelium-dependent vasorelaxing activity of wine and other grape products.
  29. (2009). Endothelium-independent vasorelaxant effect of sodium ferulate on rat thoracic aorta.
  30. (1998). Exercise capacity in heart transplant recipients: relation to impaired endothelium-dependent vasodilation of the peripheral microcirculation. doi
  31. (1979). Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet i,
  32. (2002). Factors critical to iontophoretic assessment of vascular reactivity: implications for clinical studies of endothelial dysfunction. doi
  33. (2008). Fish oil fatty acids improve postprandial vascular reactivity in healthy men. doi
  34. (1995). Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study.
  35. (2007). Grape juice causes endothelium-dependent relaxation via a redox-sensitive Src- and Akt-dependent activation of eNOS.
  36. (1999). Health effects of vegetables and fruit: assessing mechanisms of action in human experimental studies.
  37. (2008). How do dietary flavanols improve vascular function? A position paper.
  38. (1994). Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. doi
  39. (2000). Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability.
  40. (2002). Matrix metalloproteinases and atherosclerotic plaque instability. doi
  41. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
  42. (1998). Natural dietary polyphenolic compounds cause endotheliumdependent vasorelaxation in rat thoracic aorta.
  43. (2001). Novel biomarkers of the metabolism of caffeic acid derivatives in vivo.
  44. (2006). Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine.
  45. (2007). Reduced secretion and expression of gelatinase profile in Toxoplasma gondii-infected human monocytic cells. doi
  46. (1988). Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. doi
  47. (1998). The basic chemistry of nitrogen monoxide and peroxynitrite.
  48. (2002). The metabolic fate of dietary polyphenols in humans.
  49. (2003). Total and corrected antioxidant capacity in hemodialyzed patients.
  50. (2000). Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer.
  51. (2001). Unraveling peroxynitrite formation in biological systems.
  52. (1999). Urinary excretion of hydroxycinnamates and flavonoids after oral and intravenous administration.
  53. (2003). Vascular effects of caffeic acid phenethyl ester (CAPE) on isolated rat thoracic aorta.
  54. (2004). Vascular effects of wine polyphenols.
  55. (1992). Wine, alcohol, platelets, and the French paradox for coronary heart disease. doi
  56. (2003). Wine, liquor, beer, and mortality.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.